Use of macrolides in lung diseases: recent literature controversies;Uso de macrolídeos em doenças pulmonares: controvérsias da literatura recente

Jornal de Pediatria

Volumn 91, Issue 6, 2015, Pages S52-S60

  da Silva Filho, Luiz Vicente Ribeiro Ferreira ^a,b   Pinto, Leonardo Araujo ^c   Stein, Renato T ^c  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

^b HOSPITAL ISRAELITA ALBERT EINSTEIN   (Brazil)

^c PONTIFICAL CATHOLIC UNIVERSITY OF RIO GRANDE DO SUL   (Brazil)

Author keywords

Adolescents; Children; Inflammation; Macrolides; Pulmonary diseases

Indexed keywords

MACROLIDE; ANTIINFECTIVE AGENT;

ANTIINFLAMMATORY ACTIVITY; ASTHMA; BRONCHIECTASIS; BRONCHIOLITIS OBLITERANS; CHILDHOOD DISEASE; CYSTIC FIBROSIS; DRUG INDICATION; DRUG MECHANISM; HOST RESISTANCE; HUMAN; LUNG DISEASE; LUNG FUNCTION; LUNG PARENCHYMA; MUCUS SECRETION; PSEUDOMONAS AERUGINOSA; RECURRENT DISEASE; SHORT SURVEY; SIGNAL TRANSDUCTION; SYSTEMATIC REVIEW; VIRAL BRONCHIOLITIS; WHEEZING; ADOLESCENT; ANTIBIOTIC RESISTANCE; BRONCHIOLITIS; CHILD; DRUG EFFECTS; LUNG DISEASES;

ADOLESCENT; ANTI-BACTERIAL AGENTS; ASTHMA; BRONCHIECTASIS; BRONCHIOLITIS; CHILD; CYSTIC FIBROSIS; DRUG RESISTANCE, BACTERIAL; HUMANS; LUNG DISEASES; MACROLIDES;

EID: 84979853684     PISSN: 00217557     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jped.2015.08.002     Document Type: Short Survey

References (67)

1. 1 Mazzei, T., Mini, E., Novelli, A., Periti, P., Chemistry and mode of action of macrolides. J Antimicrob Chemother 31 (1993), 1–9.
2. 2 Martin, R.J., Kraft, M., Chu, H.W., Berns, E.A., Cassell, G.H., A link between chronic asthma and chronic infection. J Allergy Clin Immunol 107 (2001), 595–601.
3. 3 Agarwal, A., Chander, Y., Chronic Chlamydia pneumoniae infection and bronchial asthma: is there a link?. Indian J Med Microbiol 26 (2008), 338–341.
4. 4 Kanoh, S., Rubin, B.K., Mechanisms of action and clinical application of macrolides as immunomodulatory medications. Clin Microbiol Rev 23 (2010), 590–615.
5. 5 Spagnolo, P., Fabbri, L.M., Bush, A., Long-term macrolide treatment for chronic respiratory disease. Eur Respir J 42 (2013), 239–251.
6. 6 Poletti, V., Casoni, G., Chilosi, M., Zompatori, M., Diffuse panbronchiolitis. Eur Respir J 28 (2006), 862–871.
7. 7 Lin, X., Lu, J., Yang, M., Dong, B.R., Wu, H.M., Macrolides for diffuse panbronchiolitis. Cochrane Database Syst Rev, 1, 2015, CD007716.
8. 8 Goossens, H., Antibiotic consumption and link to resistance. Clin Microbiol Infect 15 (2009), 12–15.
9. 9 Valery, P.C., Morris, P.S., Byrnes, C.A., Grimwood, K., Torzillo, P.J., Bauert, P.A., et al. Long-term azithromycin for Indigenous children with non-cystic-fibrosis bronchiectasis or chronic suppurative lung disease (Bronchiectasis Intervention Study): a multicentre, double-blind, randomised controlled trial. Lancet Respir Med 1 (2013), 610–620.
10. 10 Albert, R.K., Schuller, J.L., Network, C.C., Macrolide antibiotics and the risk of cardiac arrhythmias. Am J Respir Crit Care Med 189 (2014), 1173–1180.
11. 11 Guyatt, G.H., Oxman, A.D., Vist, G.E., Kunz, R., Falck-Ytter, Y., Alonso Coello, P., et al. GRADE: an emerging consensus on rating quality of evidence and strength of recommendations. BMJ 336 (2008), 924–926.
12. 12 Clementsen, P., Permin, H., Norn, S., Chlamydia pneumoniae infection and its role in asthma and chronic obstructive pulmonary disease. J Investig Allergol Clin Immunol 12 (2002), 73–79.
13. 13 Johnston, S.L., Blasi, F., Black, P.N., Martin, R.J., Farrell, D.J., Nieman, R.B., et al. The effect of telithromycin in acute exacerbations of asthma. N Engl J Med 354 (2006), 1589–1600.
14. 14 Simpson, J.L., Powell, H., Boyle, M.J., Scott, R.J., Gibson, P.G., Clarithromycin targets neutrophilic airway inflammation in refractory asthma. Am J Respir Crit Care Med 177 (2008), 148–155.
15. 15 Strunk, R.C., Bacharier, L.B., Phillips, B.R., Szefler, S.J., Zeiger, R.S., Chinchilli, V.M., et al. Azithromycin or montelukast as inhaled corticosteroid-sparing agents in moderate-to-severe childhood asthma study. J Allergy Clin Immunol, 122, 2008 1138–1144.e4.
16. 16 Richeldi, L., Ferrara, G., Fabbri, L.M., Lasserson, T.J., Gibson, P.G., Macrolides for chronic asthma. Cochrane Database Syst Rev, 2005, CD002997.
17. 17 Reiter, J., Demirel, N., Mendy, A., Gasana, J., Vieira, E.R., Colin, A.A., et al. Macrolides for the long-term management of asthma – a meta-analysis of randomized clinical trials. Allergy 68 (2013), 1040–1049.
18. 18 Brusselle, G.G., Vanderstichele, C., Jordens, P., Deman, R., Slabbynck, H., Ringoet, V., et al. Azithromycin for prevention of exacerbations in severe asthma (AZISAST): a multicentre randomised double-blind placebo-controlled trial. Thorax 68 (2013), 322–329.
19. 19 Hall, C.B., Therapy for bronchiolitis: when some become none. N Engl J Med 357 (2007), 402–404.
20. 20 Tahan, F., Ozcan, A., Koc, N., Clarithromycin in the treatment of RSV bronchiolitis: a double-blind, randomised, placebo-controlled trial. Eur Respir J 29 (2007), 91–97.
21. 21 Kneyber, M.C., Kimpen, J.L., Antibiotics in RSV bronchiolitis: still no evidence of effect. Eur Respir J, 29, 2007, 1285.
22. 22 Korppi, M., Macrolides and bronchiolitis in infants. Eur Respir J 29 (2007), 1283–1284 [author reply 1284–5].
23. 23 Kneyber, M.C., van Woensel, J.B., Uijtendaal, E., Uiterwaal, C.S., Kimpen, J.L., Dutch Antibiotics in RSVTRG. Azithromycin does not improve disease course in hospitalized infants with respiratory syncytial virus (RSV) lower respiratory tract disease: a randomized equivalence trial. Pediatr Pulmonol 43 (2008), 142–149.
24. 24 Pinto, L.A., Pitrez, P.M., Luisi, F., de Mello, P.P., Gerhardt, M., Ferlini, R., et al. Azithromycin therapy in hospitalized infants with acute bronchiolitis is not associated with better clinical outcomes: a randomized, double-blinded, and placebo-controlled clinical trial. J Pediatr 161 (2012), 1104–1108.
25. 25 McCallum, G.B., Morris, P.S., Chatfield, M.D., Maclennan, C., White, A.V., Sloots, T.P., et al. A single dose of azithromycin does not improve clinical outcomes of children hospitalised with bronchiolitis: a randomised, placebo-controlled trial. PLOS ONE, 8, 2013, e74316.
26. 26 Farley, R., Spurling, G.K., Eriksson, L., Del Mar, C.B., Antibiotics for bronchiolitis in children under two years of age. Cochrane Database Syst Rev, 10, 2014, CD005189.
27. 27 Beigelman, A., Isaacson-Schmid, M., Sajol, G., Baty, J., Rodriguez, O.M., Leege, E., et al. Randomized trial to evaluate azithromycin's effects on serum and upper airway IL-8 levels and recurrent wheezing in infants with respiratory syncytial virus bronchiolitis. J Allergy Clin Immunol 134 (2014), 1171–1178.
28. 28 Smyth, R.L., Mobbs, K.J., O'Hea, U., Ashby, D., Hart, C.A., Respiratory syncytial virus bronchiolitis: disease severity, interleukin-8, and virus genotype. Pediatr Pulmonol 33 (2002), 339–346.
29. 29 Rowe, S.M., Miller, S., Sorscher, E.J., Cystic fibrosis. N Engl J Med 352 (2005), 1992–2001.
30. 30 Silva Filho, L.V., Ferreira, F. de A., Reis, F.J., Britto, M.C., Levy, C.E., Clark, O., et al. Pseudomonas aeruginosa infection in patients with cystic fibrosis: scientific evidence regarding clinical impact, diagnosis, and treatment. J Bras Pneumol 39 (2013), 495–512.
31. 31 Shinkai, M., Rubin, B.K., Macrolides and airway inflammation in children. Paediatr Respir Rev 6 (2005), 227–235.
32. 32 McArdle, J.R., Talwalkar, J.S., Macrolides in cystic fibrosis. Clin Chest Med 28 (2007), 347–360.
33. 33 Equi, A., Balfour-Lynn, I.M., Bush, A., Rosenthal, M., Long term azithromycin in children with cystic fibrosis: a randomised, placebo-controlled crossover trial. Lancet 360 (2002), 978–984.
34. 34 Saiman, L., Marshall, B.C., Mayer-Hamblett, N., Burns, J.L., Quittner, A.L., Cibene, D.A., et al. Azithromycin in patients with cystic fibrosis chronically infected with Pseudomonas aeruginosa: a randomized controlled trial. JAMA 290 (2003), 1749–1756.
35. 35 Saiman, L., Anstead, M., Mayer-Hamblett, N., Lands, L.C., Kloster, M., Hocevar-Trnka, J., et al. Effect of azithromycin on pulmonary function in patients with cystic fibrosis uninfected with Pseudomonas aeruginosa: a randomized controlled trial. JAMA 303 (2010), 1707–1715.
36. 36 Cai, Y., Chai, D., Wang, R., Bai, N., Liang, B.B., Liu, Y., Effectiveness and safety of macrolides in cystic fibrosis patients: a meta-analysis and systematic review. J Antimicrob Chemother 66 (2011), 968–978.
37. 37 Southern, K.W., Barker, P.M., Solis-Moya, A., Patel, L., Macrolide antibiotics for cystic fibrosis. Cochrane Database Syst Rev, 11, 2012, CD002203.
38. 38 Robinson, P., Schechter, M.S., Sly, P.D., Winfield, K., Smith, J., Brennan, S., et al. Clarithromycin therapy for patients with cystic fibrosis: a randomized controlled trial. Pediatr Pulmonol 47 (2012), 551–557.
39. 39 Barker, A.F., Bergeron, A., Rom, W.N., Hertz, M.I., Obliterative bronchiolitis. N Engl J Med 370 (2014), 1820–1828.
40. 40 Christie, J.D., Edwards, L.B., Kucheryavaya, A.Y., Benden, C., Dipchand, A.I., Dobbels, F., et al. The Registry of the International Society for Heart and Lung Transplantation: 29th adult lung and heart-lung transplant report – 2012. J Heart Lung Transplant 31 (2012), 1073–1086.
41. 41 Ryu, J.H., Myers, J.L., Swensen, S.J., Bronchiolar disorders. Am J Respir Crit Care Med 168 (2003), 1277–1292.
42. 42 Mauad, T., Dolhnikoff, M., Sao Paulo Bronchiolitis Obliterans Study G. Histology of childhood bronchiolitis obliterans. Pediatr Pulmonol 33 (2002), 466–474.
43. 43 Costa, C.L., Spilborghs, G.M., Martins, M.A., Saldiva, P.H., Mauad, T., Nitric acid-induced bronchiolitis in rats mimics childhood bronchiolitis obliterans. Respiration 72 (2005), 642–649.
44. 44 Colom, A.J., Teper, A.M., Vollmer, W.M., Diette, G.B., Risk factors for the development of bronchiolitis obliterans in children with bronchiolitis. Thorax 61 (2006), 503–506.
45. 45 Perez, T., Remy-Jardin, M., Cortet, B., Airways involvement in rheumatoid arthritis: clinical, functional, and HRCT findings. Am J Respir Crit Care Med 157 (1998), 1658–1665.
46. 46 Ratanatharathorn, V., Ayash, L., Lazarus, H.M., Fu, J., Uberti, J.P., Chronic graft-versus-host disease: clinical manifestation and therapy. Bone Marrow Transplant 28 (2001), 121–129.
47. 47 Smith, K.J., Dishop, M.K., Fan, L.L., Moonnumakal, S.P., Smith, E.O.B., Bayindir, P., et al. Diagnosis of bronchiolitis obliterans with computed tomography in children. Pediatr Allergy Immunol Pulmonol 23 (2010), 253–259.
48. 48 Vos, R., Vanaudenaerde, B.M., Verleden, S.E., Ruttens, D., Vaneylen, A., Van Raemdonck, D.E., et al. Anti-inflammatory and immunomodulatory properties of azithromycin involved in treatment and prevention of chronic lung allograft rejection. Transplantation 94 (2012), 101–109.
49. 49 Khalid, M., Al Saghir, A., Saleemi, S., Al Dammas, S., Zeitouni, M., Al Mobeireek, A., et al. Azithromycin in bronchiolitis obliterans complicating bone marrow transplantation: a preliminary study. Eur Respir J 25 (2005), 490–493.
50. 50 Lam, D.C., Lam, B., Wong, M.K., Lu, C., Au, W.Y., Tse, E.W., et al. Effects of azithromycin in bronchiolitis obliterans syndrome after hematopoietic SCT – a randomized double-blinded placebo-controlled study. Bone Marrow Transplant 46 (2011), 1551–1556.
51. 51 Federica, M., Nadia, S., Monica, M., Alessandro, C., Tiberio, O., Francesco, B., et al. Clinical and immunological evaluation of 12-month azithromycin therapy in chronic lung allograft rejection. Clin Transplant 25 (2011), E381–E389.
52. 52 Vos, R., Vanaudenaerde, B.M., Verleden, S.E., De Vleeschauwer, S.I., Willems-Widyastuti, A., Van Raemdonck, D.E., et al. A randomised controlled trial of azithromycin to prevent chronic rejection after lung transplantation. Eur Respir J 37 (2011), 164–172.
53. 53 Jain, R., Hachem, R.R., Morrell, M.R., Trulock, E.P., Chakinala, M.M., Yusen, R.D., et al. Azithromycin is associated with increased survival in lung transplant recipients with bronchiolitis obliterans syndrome. J Heart Lung Transplant 29 (2010), 531–537.
54. 54 Kingah, P.L., Muma, G., Soubani, A., Azithromycin improves lung function in patients with post-lung transplant bronchiolitis obliterans syndrome: a meta-analysis. Clin Transplant 28 (2014), 906–910.
55. 55 Teixeira, M.F., Rodrigues, J.C., Leone, C., Adde, F.V., Acute bronchodilator responsiveness to tiotropium in postinfectious bronchiolitis obliterans in children. Chest 144 (2013), 974–980.
56. 56 Tomikawa, S.O., Adde, F.V., da Silva Filho, L.V., Leone, C., Rodrigues, J.C., Follow-up on pediatric patients with bronchiolitis obliterans treated with corticosteroid pulse therapy. Orphanet J Rare Dis, 9, 2014, 128.
57. 57 Li, Y.N., Liu, L., Qiao, H.M., Cheng, H., Cheng, H.J., Post-infectious bronchiolitis obliterans in children: a review of 42 cases. BMC Pediatr, 14, 2014, 238.
58. 58 Hill, A.T., Pasteur, M., Cornford, C., Welham, S., Bilton, D., Primary care summary of the British Thoracic Society Guideline on the management of non-cystic fibrosis bronchiectasis. Prim Care Respir J 20 (2011), 135–140.
59. 59 Altenburg, J., de Graaff, C.S., Stienstra, Y., Sloos, J.H., van Haren, E.H., Koppers, R.J., et al. Effect of azithromycin maintenance treatment on infectious exacerbations among patients with non-cystic fibrosis bronchiectasis: the BAT randomized controlled trial. JAMA 309 (2013), 1251–1259.
60. 60 Santamaria, F., Montella, S., Pifferi, M., Ragazzo, V., De Stefano, S., De Paulis, N., et al. A descriptive study of non-cystic fibrosis bronchiectasis in a pediatric population from central and southern Italy. Respiration 77 (2009), 160–165.
61. 61 Valery, P.C., Morris, P.S., Grimwood, K., Torzillo, P.J., Byrnes, C.A., Masters, I.B., et al. Azithromycin for indigenous children with bronchiectasis: study protocol for a multi-centre randomized controlled trial. BMC Pediatr, 12, 2012, 122.
62. 62 Haworth, C.S., Bilton, D., Elborn, J.S., Long-term macrolide maintenance therapy in non-CF bronchiectasis: evidence and questions. Respir Med 108 (2014), 1397–1408.
63. 63 Gao, Y.H., Guan, W.J., Xu, G., Tang, Y., Gao, Y., Lin, Z.Y., et al. Macrolide therapy in adults and children with non-cystic fibrosis bronchiectasis: a systematic review and meta-analysis. PLOS ONE, 9, 2014, e90047.
64. 64 Fan, L.C., Lu, H.W., Wei, P., Ji, X.B., Liang, S., Xu, J.F., Effects of long-term use of macrolides in patients with non-cystic fibrosis bronchiectasis: a meta-analysis of randomized controlled trials. BMC Infect Dis, 15, 2015, 160.
65. 65 Chang, A.B., Bell, S.C., Torzillo, P.J., King, P.T., Maguire, G.P., Byrnes, C.A., et al. Chronic suppurative lung disease and bronchiectasis in children and adults in Australia and New Zealand Thoracic Society of Australia and New Zealand guidelines. Med J Aust, 202, 2015, 130.
66. 66 Klugman, K.P., Lonks, J.R., Hidden epidemic of macrolide-resistant pneumococci. Emerg Infect Dis 11 (2005), 802–807.
67. 67 Chancey, S.T., Agrawal, S., Schroeder, M.R., Farley, M.M., Tettelin, H., Stephens, D.S., Composite mobile genetic elements disseminating macrolide resistance in Streptococcus pneumoniae. Front Microbiol, 6, 2015, 26.